- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05774600
Virtual Sun Safe Workplaces Ph II (SSW Works)
March 17, 2026 updated by: Klein Buendel, Inc.
SSW Works: A Virtual Learning Environment for Occupational Skin Cancer Prevention Ph II
Americans who work outdoors are exposed to an extreme amount of solar ultraviolet radiation over a lifetime that substantially increases their risk for developing skin cancer.
In Phase I, the feasibility of a virtual learning environment (VLE) for distributing the effective Sun Safe Workplaces (SSW) intervention to American employers will be established with input from senior managers and Hispanic and African American outdoor workers and development and evaluation of a prototype of the SSW Works VLE.
In Phase II, the full SSW Works will be produced and tested for effectiveness at improving outdoor workers' sun protection in a randomized trial enrolling employers nationwide.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Americans who work outdoors are exposed to an extreme amount of solar ultraviolet radiation (UV) over a lifetime that substantially increases their risk for developing skin cancer.
Annually, skin cancer is diagnosed in over 3.5 million U.S. adults, melanoma kills nearly 7,000 Americans, and treatment costs at least $8 billion.
The U.S. Surgeon General has identified occupational sun safety as a national priority.
The team has spent the past two decades developing a successful comprehensive approach to occupational sun protection in 5 trials funded largely by the National Cancer Institute.
Sun Safe Workplaces (SSW) combines policy and education to increase workplace actions on sun safety and employee sun protection practices.
In this SBIR Fast-Track application, the investigators will develop a virtual learning environment (VLE), SSW Works, to distribute the SSW program to American workplaces.
It will be comprised of a database, content management (interactive toolbox), and media platform (trackable training) that tailors the SSW program to management's readiness to innovate on sun safety based Diffusion of Innovations Theory.
SSW Works will better integrate SSW into safety training by improving appropriateness for Hispanic and African American workers and conforming with the latest learning management systems technology (LMS).
Strong scientific premise comes from the published literature and the team's 5 previous studies that demonstrated SSW is feasible and effective in public works, public safety, and outdoor recreation workplaces.
The Phase I specific aims will establish the feasibility of SSW Works by 1) creating and validating an algorithm to tailor resources and implementation strategies to employers' stages in the diffusion of innovations process; 2) identifying unique attitudes, barriers, and practices related to sun safety among Hispanic and African American employees in focus group discussion and adjusting the SSW content; and 3) creating a prototype of the SSW Works VLE, including inputs, staging algorithm and tailored report, employee training compatible with a popular LMS, and storyboards of brief videos for managers and employees and testing it for feasibility and usability with managers and Hispanic and African American outdoor workers, and confirming that the training can operate within a popular LMS.
In Phase II, SSW Works will be fully programmed and tested for effectiveness by achieving the specific aims of: 1) producing the full SSW Works, in English and Spanish, for distribution of the evidence-based SSW and 2) conducting a randomized controlled trial with 20 workplaces evaluating impact of SSW distributed over the SSW Works on employees' sun safety practices (primary outcome).
The primary hypothesis is: compared to employers in the minimal information control group, employers assigned to receive SSW Works will have employees that practice more sun protection at posttest.
The SBIR Fast-Track research is significant and innovative.
SSW Works will have high impact and commercial potential because outdoor workforce is large and at very high risk for skin cancer, improving sun safety will reduce health care costs and save lives, and there are few commercial competitors.
Study Type
Interventional
Enrollment (Actual)
543
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Golden, Colorado, United States, 80401
- Klein Buendel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Manager Inclusion Criteria:
- Employed in a manager or supervisory position
- Responsible for worksite safety / health policy or education
- Read English or Spanish
- Consent to participate
- Complete the pre-test survey
- Employee Inclusion Criteria:
- Employed part-time / full-time at a participating employer
- Work at least 5 hours outdoors a week
- Read English or Spanish
- Consent to participate
- Complete the pre-test survey
Exclusion Criteria:
- Manager Exclusion Criteria:
- Read a language other than English or Spanish
- Employee Exclusion Criteria:
- Read a language other than English or Spanish
- Work exclusively indoors
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SSW Works
SSW Works, is a virtual learning environment (VLE) for automated, comprehensive, on-demand, tailored distribution of the SSW program to private and public employers with outdoor workers.
It will be delivered in both English and Spanish to managers and employees who work outdoors to reduce risk for skin cancer.
|
SSW Works is a behavioral, culturally tailored online intervention for skin cancer prevention amongst outdoor workers in the United States.
|
|
Active Comparator: Minimal Information Control
Workplaces randomized to the control condition will receive a set of printed materials on occupational sun safety (1 mailing per year) as an attention control.
These will include posters on personal protection and skin cancer incidence, risk assessment brochure, American Academy of Dermatology SPOT bookmark showing the ABCDEs of melanoma and skin self-examination, and a sun safety tip card from OSHA.
|
Provision of online materials for skin cancer prevention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline Employee Sun Protection Practices at 1 Year
Time Frame: Baseline assessment, 1 year assessment
|
Employees will report frequency of sun protection at work (i.e., sunscreen with SPF 30+, long-sleeved shirts, long pants, hat with wide-brim, sunglasses, shade use, limit midday sun exposure, and have sunscreen, hat and eye protection at all times [1=never, 5=always]).
SPF 30+ is advised in SSW to account for typical under-application that reduces effective SPF.
|
Baseline assessment, 1 year assessment
|
|
Percentage Change From Baseline Employee Sunburn Prevalence at 1 Year
Time Frame: Baseline assessment, 1 year assessment
|
The percentage change in employees reporting any sunburn in the last 3 months on the job from pretest to posttest.
|
Baseline assessment, 1 year assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mary Buller, MA, Klein Buendel, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Actual)
February 25, 2025
Study Completion (Actual)
August 28, 2025
Study Registration Dates
First Submitted
February 9, 2023
First Submitted That Met QC Criteria
March 7, 2023
First Posted (Actual)
March 17, 2023
Study Record Updates
Last Update Posted (Actual)
March 19, 2026
Last Update Submitted That Met QC Criteria
March 17, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0339
- 4R44CA257778-02 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Cancer
-
Abramson Cancer Center at Penn MedicineRecruitingSkin Cancer Face | Skin Cancer ScalpUnited States
-
University of HawaiiVA Palo Alto Health Care SystemCompletedCancer, Other Than Non-melanoma Skin CancerUnited States
-
EnlundCompletedBreast Cancer | Skin Cancer | Colo-rectal CancerSweden
-
Xoft, Inc.Eminence Clinical Research, Inc.CompletedNonmelanoma Skin CancerUnited States
-
SciBase ABRecruitingKeratinocyte Skin CancerGermany
-
Rutgers, The State University of New JerseyCompleted
-
University of MichiganBlue Cross Blue Shield of Michigan FoundationCompletedSkin Cancer PreventionUnited States
-
McMaster UniversityRecruitingSkin Cancer, Basal Cell Skin Cancer Skin Cancer, Non-Melanoma Skin Cancers - Squamous Cell Carcinoma Patient SatisfactionCanada
-
National University Hospital, SingaporeNot yet recruitingSkin Cancer | Skin Cancer Prevention | Benign Skin Growth
-
University of Alabama at BirminghamNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
Clinical Trials on SSW Works
-
MGH Institute of Health ProfessionsMassachusetts General HospitalRecruitingHematopoietic Stem Cell TransplantationUnited States
-
GlaxoSmithKlineCompleted
-
Klein Buendel, Inc.National Cancer Institute (NCI); Kaiser PermanenteCompletedSkin CancerUnited States
-
Bezmialem Vakif UniversityNot yet recruitingJoint Prosthesis; Complications, Infection or InflammationTurkey
-
Agency for Healthcare Research and Quality (AHRQ)Massachusetts eHealth CollaborativeCompleted
-
Midwest Evaluation & ResearchGoodwill of Central TexasCompleted
-
GlaxoSmithKlineCompleted
-
Virginia Polytechnic Institute and State UniversityCarilion Clinic; Thomas Jefferson University; Mazzoni Health Center; Diversity...TerminatedSuicide | Engagement, PatientUnited States
-
GlaxoSmithKlineCompleted